RSAR: Post-marketing RX Drug Abuse Surveillance Data - IBH (Data Source)
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
-
- CDER Acquisition Liaison cderacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is seeking a contractor to provide post-marketing surveillance data related to prescription drug abuse through the Intelligent Behavioral Health (IBH) data source. This recompete requirement involves collecting and managing post-marketing data that supports FDA's monitoring and regulatory oversight of controlled substances and their abuse potential. The solicitation is expected to be released on September 1, 2025, with an estimated contract award targeted for March 1, 2026.
The estimated award value ranges from $250,000 to $700,000, reflecting the scope and duration of the data surveillance services required. This procurement falls under NAICS code 541990 (All Other Professional, Scientific, and Technical Services) and does not utilize a small business set-aside. For inquiries regarding this opportunity, interested parties should contact the FDA's Acquisition Liaison at cderacquisitions@fda.hhs.gov.
Forecast text
Post-marketing RX Drug Abuse Surveillance Data - IBH (Recompete FY26)
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast